Jjpb1212sp. z o.o.
Research and experimental development in natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2025-12-13
Share capital
5 000,00 PLN
Registered address
ul. Bobrowiecka 6, 00-728 Warszawa, Poland
Electronic delivery address
AE:PL-15743-60442-UHVTF-35
Industry
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Paweł Aleksander Szczepański — Management Board Member
Dariusz Krzysztof Piątek — Management Board Member
Grzegorz Roman Kotowski — Management Board Member
Manner of representation
In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 99 | $1,337.12 | 99% | |
Others | 1 | $13.51 | 1% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Julia Anastazja Starak (37) | Pośrednia kontrola właścicielska poprzez posiadanie ok. 45% udziałów w spółce, która posiada 99% udziałów w zgłaszanej spółce. | |
Patrick Rafał Starak (53) | Pośrednia kontrola właścicielska poprzez posiadanie ok. 45% udziałów w spółce, która posiada 99% udziałów w zgłaszanej spółce. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| PratiaS.A. | $28,984,298.31 | pratia.com | ||
| Lymelab Pharma sp. z o.o.sp. k. | $424,756.39 | lymelabpharma.com | ||
| Oasis DiagnosticsS.A. | $282,613.94 | oasis-diagnostics.com | ||
| NanosanguisS.A. | $192,701.50 | nanosanguis.com | ||
| NanovelosS.A. | $24,842.03 | nanovelos.com | ||
| Nanostalsp. z o.o. | $8,607.48 | nanostal.com | ||
| NanotheaS.A. | $115.78 | nanothea.com | ||
| MolecureS.A. | $10.77 | molecure.com | ||
| Biorenomésp. z o.o. | — | biorenome.pl | ||
| Syn2bioS.A. | — | syn2bio.pl |
FAQ
The main business activity of Jjpb1212 focuses on research and experimental development in natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on December 13, 2025.
The headquarters is located at: ul. Bobrowiecka 6, 00-728 Warszawa.
The management board includes Paweł Aleksander Szczepański (Member of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-25
